ABG Sundal Collier acted as joint bookrunner in connection with the NOK 43 million financing round in SpinChip Diagnostics ASA

On 8 January 2024, SpinChip Diagnostics ASA (“SpinChip” or the “Company”) announced the successful completion of a convertible loan, raising gross proceeds of NOK 43 million. The financing round was well supported by existing shareholders and attracted participation from new investors.
The net proceeds from the convertible loan will be used to further advance SpinChip’s proprietary point-of-care (POC) in vitro diagnostics platform, prepare for a CE mark in 2025, and for general corporate purposes.
ABGSC acted as joint bookrunner to the Company, and would like to extend its gratitude to the Company for the vote of confidence.